BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 18164829)

  • 1. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C; Suh J; Stea B; Nabid A; Hackman J
    Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.
    Regine WF; Schmitt FA; Scott CB; Dearth C; Patchell RA; Nichols RC; Gore EM; Franklin RL; Suh JH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1346-52. PubMed ID: 15050309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.
    Brown PD; Asher AL; Farace E
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1305-9. PubMed ID: 18234426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
    Brown PD; Buckner JC; O'Fallon JR; Iturria NL; Brown CA; O'Neill BP; Scheithauer BW; Dinapoli RP; Arusell RM; Curran WJ; Abrams R; Shaw EG
    J Clin Oncol; 2003 Jul; 21(13):2519-24. PubMed ID: 12829670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
    Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
    Li J; Bentzen SM; Renschler M; Mehta MP
    J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
    Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
    Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
    Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of whole brain re-irradiation for brain metastases--single centre experience.
    Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03.
    Corn BW; Wang M; Fox S; Michalski J; Purdy J; Simpson J; Kresl J; Curran WJ; Diaz A; Mehta M; Movsas B
    J Neurooncol; 2009 Nov; 95(2):247-257. PubMed ID: 19533025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
    Grosshans DR; Meyers CA; Allen PK; Davenport SD; Komaki R
    Cancer; 2008 Feb; 112(3):589-95. PubMed ID: 18098269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.